These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25056838)

  • 21. Can we still afford bladder cancer?
    Stenzl A; Hennenlotter J; Schilling D
    Curr Opin Urol; 2008 Sep; 18(5):488-92. PubMed ID: 18670272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bladder cancer.
    Clark PE
    Curr Opin Oncol; 2007 May; 19(3):241-7. PubMed ID: 17414643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
    Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
    Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic impact of tumor markers in bladder cancer surveillance.
    Hong YM; Loughlin KR
    Urology; 2008 Jan; 71(1):131-5. PubMed ID: 18242381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature.
    Rink M; Babjuk M; Catto JW; Jichlinski P; Shariat SF; Stenzl A; Stepp H; Zaak D; Witjes JA
    Eur Urol; 2013 Oct; 64(4):624-38. PubMed ID: 23906669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guérin-Unresponsive Carcinoma In Situ of the Bladder.
    Wymer KM; Sharma V; Saigal CS; Chamie K; Litwin MS; Packiam VT; Mossanen M; Pagliaro LC; Borah BJ; Boorjian SA
    J Urol; 2021 May; 205(5):1326-1335. PubMed ID: 33347775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between volume and charges for most frequently performed ambulatory and nonambulatory surgery for bladder cancer. Is more cheaper?
    Konety BR; Dhawan V; Allareddy V; O'Donnell MA
    J Urol; 2004 Sep; 172(3):1056-61. PubMed ID: 15311037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder cancer.
    Barocas DA; Clark PE
    Curr Opin Oncol; 2008 May; 20(3):307-14. PubMed ID: 18391631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and management of superficial bladder cancer.
    Amling CL
    Curr Probl Cancer; 2001; 25(4):219-78. PubMed ID: 11514784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of urine cytology as a routine work-up in the detection of recurrence in patients with prior non-muscle-invasive bladder cancer: practicality and cost-effectiveness.
    Ok BG; Ji YS; Ko YH; Song PH
    Korean J Urol; 2014 Oct; 55(10):650-5. PubMed ID: 25324947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary cost analysis of single instillation of mitomycin after transurethral resection of bladder tumor in a universal health care system.
    Feifer A; Xie X; Brophy JM; Segal R; Kassouf W
    Urology; 2010 Sep; 76(3):652-6. PubMed ID: 20394970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis.
    Lotan Y; Svatek RS; Sagalowsky AI
    Cancer; 2006 Sep; 107(5):982-90. PubMed ID: 16862567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy.
    Lee R; Ng CK; Shariat SF; Borkina A; Guimento R; Brumit KF; Scherr DS
    BJU Int; 2011 Dec; 108(11):1886-92. PubMed ID: 21501370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature.
    Joyce DD; Sharma V; Williams SB
    Pharmacoeconomics; 2023 Jul; 41(7):751-769. PubMed ID: 37088844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors.
    Madeb R; Golijanin D; Noyes K; Fisher S; Stephenson JJ; Long SR; Knopf J; Lyman GH; Messing EM
    Cancer; 2009 Jun; 115(12):2660-70. PubMed ID: 19455607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perioperative instillation therapy in superficial bladder cancer: is it effective regarding outcome and costs?
    Engel RP; Witjes JA
    Curr Opin Urol; 2009 Sep; 19(5):511-5. PubMed ID: 19553821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photodynamic diagnostics and noninvasive bladder cancer: is it cost-effective in long-term application? A Germany-based cost analysis.
    Burger M; Zaak D; Stief CG; Filbeck T; Wieland WF; Roessler W; Denzinger S
    Eur Urol; 2007 Jul; 52(1):142-7. PubMed ID: 17267099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project.
    Hurle R; Lazzeri M; Vanni E; Lughezzani G; Buffi N; Casale P; Saita A; Morenghi E; Forni G; Cardone P; Lista G; Colombo P; Peschechera R; Pasini L; Zandegiacomo S; Benetti A; Maffei D; Vavassori I; Guazzoni G
    J Urol; 2018 Feb; 199(2):401-406. PubMed ID: 28847481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
    Babjuk M; Böhle A; Burger M; Capoun O; Cohen D; Compérat EM; Hernández V; Kaasinen E; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Soukup V; Sylvester RJ; Zigeuner R
    Eur Urol; 2017 Mar; 71(3):447-461. PubMed ID: 27324428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Lotan Y; Woldu SL; Sanli O; Black P; Milowsky MI
    BJU Int; 2018 Sep; 122(3):434-440. PubMed ID: 29603871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.